Copyright Reports & Markets. All rights reserved.

Global G-CSF Biosimilars Market Research Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 G-CSF Biosimilars Market Overview

      • 1.1 Product Overview and Scope of G-CSF Biosimilars
      • 1.2 G-CSF Biosimilars Segment by Type
        • 1.2.1 Global G-CSF Biosimilars Production Growth Rate Comparison by Type (2014-2025)
        • 1.2.2 Human Growth Hormone
        • 1.2.3 Erythropoietin
        • 1.2.4 Monoclonal Antibodies
        • 1.2.5 Insulin
        • 1.2.6 Interferon
        • 1.2.7 Granulocyte-Colony Stimulating Factor
      • 1.3 G-CSF Biosimilars Segment by Application
        • 1.3.1 G-CSF Biosimilars Consumption Comparison by Application (2014-2025)
        • 1.3.2 Blood Disorders
        • 1.3.3 Oncology Diseases
        • 1.3.4 Chronic And Autoimmune Diseases
        • 1.3.5 Growth Hormone Deficiencies
      • 1.4 Global G-CSF Biosimilars Market by Region
        • 1.4.1 Global G-CSF Biosimilars Market Size Region
        • 1.4.2 North America Status and Prospect (2014-2025)
        • 1.4.3 Europe Status and Prospect (2014-2025)
        • 1.4.4 China Status and Prospect (2014-2025)
        • 1.4.5 Japan Status and Prospect (2014-2025)
      • 1.5 Global G-CSF Biosimilars Market Size
        • 1.5.1 Global G-CSF Biosimilars Revenue (2014-2025)
        • 1.5.2 Global G-CSF Biosimilars Production (2014-2025)

      2 Global G-CSF Biosimilars Market Competition by Manufacturers

      • 2.1 Global G-CSF Biosimilars Production Market Share by Manufacturers (2014-2019)
      • 2.2 Global G-CSF Biosimilars Revenue Share by Manufacturers (2014-2019)
      • 2.3 Global G-CSF Biosimilars Average Price by Manufacturers (2014-2019)
      • 2.4 Manufacturers G-CSF Biosimilars Production Sites, Area Served, Product Types
      • 2.5 G-CSF Biosimilars Market Competitive Situation and Trends
        • 2.5.1 G-CSF Biosimilars Market Concentration Rate
        • 2.5.2 G-CSF Biosimilars Market Share of Top 3 and Top 5 Manufacturers
        • 2.5.3 Mergers & Acquisitions, Expansion

      3 Global G-CSF Biosimilars Production Market Share by Regions

      • 3.1 Global G-CSF Biosimilars Production Market Share by Regions
      • 3.2 Global G-CSF Biosimilars Revenue Market Share by Regions (2014-2019)
      • 3.3 Global G-CSF Biosimilars Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.4 North America G-CSF Biosimilars Production
        • 3.4.1 North America G-CSF Biosimilars Production Growth Rate (2014-2019)
        • 3.4.2 North America G-CSF Biosimilars Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.5 Europe G-CSF Biosimilars Production
        • 3.5.1 Europe G-CSF Biosimilars Production Growth Rate (2014-2019)
        • 3.5.2 Europe G-CSF Biosimilars Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.6 China G-CSF Biosimilars Production (2014-2019)
        • 3.6.1 China G-CSF Biosimilars Production Growth Rate (2014-2019)
        • 3.6.2 China G-CSF Biosimilars Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.7 Japan G-CSF Biosimilars Production (2014-2019)
        • 3.7.1 Japan G-CSF Biosimilars Production Growth Rate (2014-2019)
        • 3.7.2 Japan G-CSF Biosimilars Production, Revenue, Price and Gross Margin (2014-2019)

      4 Global G-CSF Biosimilars Consumption by Regions

      • 4.1 Global G-CSF Biosimilars Consumption by Regions
      • 4.2 North America G-CSF Biosimilars Consumption (2014-2019)
      • 4.3 Europe G-CSF Biosimilars Consumption (2014-2019)
      • 4.4 China G-CSF Biosimilars Consumption (2014-2019)
      • 4.5 Japan G-CSF Biosimilars Consumption (2014-2019)

      5 Global G-CSF Biosimilars Production, Revenue, Price Trend by Type

      • 5.1 Global G-CSF Biosimilars Production Market Share by Type (2014-2019)
      • 5.2 Global G-CSF Biosimilars Revenue Market Share by Type (2014-2019)
      • 5.3 Global G-CSF Biosimilars Price by Type (2014-2019)
      • 5.4 Global G-CSF Biosimilars Production Growth by Type (2014-2019)

      6 Global G-CSF Biosimilars Market Analysis by Applications

      • 6.1 Global G-CSF Biosimilars Consumption Market Share by Application (2014-2019)
      • 6.2 Global G-CSF Biosimilars Consumption Growth Rate by Application (2014-2019)

      7 Company Profiles and Key Figures in G-CSF Biosimilars Business

      • 7.1 Pfizer
        • 7.1.1 Pfizer G-CSF Biosimilars Production Sites and Area Served
        • 7.1.2 G-CSF Biosimilars Product Introduction, Application and Specification
        • 7.1.3 Pfizer G-CSF Biosimilars Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.1.4 Main Business and Markets Served
      • 7.2 Novartis
        • 7.2.1 Novartis G-CSF Biosimilars Production Sites and Area Served
        • 7.2.2 G-CSF Biosimilars Product Introduction, Application and Specification
        • 7.2.3 Novartis G-CSF Biosimilars Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.2.4 Main Business and Markets Served
      • 7.3 Roche
        • 7.3.1 Roche G-CSF Biosimilars Production Sites and Area Served
        • 7.3.2 G-CSF Biosimilars Product Introduction, Application and Specification
        • 7.3.3 Roche G-CSF Biosimilars Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.3.4 Main Business and Markets Served
      • 7.4 Merck & Co.
        • 7.4.1 Merck & Co. G-CSF Biosimilars Production Sites and Area Served
        • 7.4.2 G-CSF Biosimilars Product Introduction, Application and Specification
        • 7.4.3 Merck & Co. G-CSF Biosimilars Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.4.4 Main Business and Markets Served
      • 7.5 Sanofi
        • 7.5.1 Sanofi G-CSF Biosimilars Production Sites and Area Served
        • 7.5.2 G-CSF Biosimilars Product Introduction, Application and Specification
        • 7.5.3 Sanofi G-CSF Biosimilars Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.5.4 Main Business and Markets Served
      • 7.6 Johnson & Johnson
        • 7.6.1 Johnson & Johnson G-CSF Biosimilars Production Sites and Area Served
        • 7.6.2 G-CSF Biosimilars Product Introduction, Application and Specification
        • 7.6.3 Johnson & Johnson G-CSF Biosimilars Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.6.4 Main Business and Markets Served
      • 7.7 Gilead Science
        • 7.7.1 Gilead Science G-CSF Biosimilars Production Sites and Area Served
        • 7.7.2 G-CSF Biosimilars Product Introduction, Application and Specification
        • 7.7.3 Gilead Science G-CSF Biosimilars Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.7.4 Main Business and Markets Served
      • 7.8 GlaxoSmithKline
        • 7.8.1 GlaxoSmithKline G-CSF Biosimilars Production Sites and Area Served
        • 7.8.2 G-CSF Biosimilars Product Introduction, Application and Specification
        • 7.8.3 GlaxoSmithKline G-CSF Biosimilars Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.8.4 Main Business and Markets Served
      • 7.9 AbbVie
        • 7.9.1 AbbVie G-CSF Biosimilars Production Sites and Area Served
        • 7.9.2 G-CSF Biosimilars Product Introduction, Application and Specification
        • 7.9.3 AbbVie G-CSF Biosimilars Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.9.4 Main Business and Markets Served
      • 7.10 Amgen
        • 7.10.1 Amgen G-CSF Biosimilars Production Sites and Area Served
        • 7.10.2 G-CSF Biosimilars Product Introduction, Application and Specification
        • 7.10.3 Amgen G-CSF Biosimilars Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.10.4 Main Business and Markets Served
      • 7.11 AstraZeneca
      • 7.12 Bayer

      8 G-CSF Biosimilars Manufacturing Cost Analysis

      • 8.1 G-CSF Biosimilars Key Raw Materials Analysis
        • 8.1.1 Key Raw Materials
        • 8.1.2 Price Trend of Key Raw Materials
        • 8.1.3 Key Suppliers of Raw Materials
      • 8.2 Proportion of Manufacturing Cost Structure
      • 8.3 Manufacturing Process Analysis of G-CSF Biosimilars
      • 8.4 G-CSF Biosimilars Industrial Chain Analysis

      9 Marketing Channel, Distributors and Customers

      • 9.1 Marketing Channel
        • 9.1.1 Direct Marketing
        • 9.1.2 Indirect Marketing
      • 9.2 G-CSF Biosimilars Distributors List
      • 9.3 G-CSF Biosimilars Customers

      10 Market Dynamics

      • 10.1 Market Trends
      • 10.2 Opportunities
      • 10.3 Market Drivers
      • 10.4 Challenges
      • 10.5 Influence Factors

      11 Global G-CSF Biosimilars Market Forecast

      • 11.1 Global G-CSF Biosimilars Production, Revenue Forecast
        • 11.1.1 Global G-CSF Biosimilars Production Growth Rate Forecast (2019-2025)
        • 11.1.2 Global G-CSF Biosimilars Revenue and Growth Rate Forecast (2019-2025)
        • 11.1.3 Global G-CSF Biosimilars Price and Trend Forecast (2019-2025)
      • 11.2 Global G-CSF Biosimilars Production Forecast by Regions (2019-2025)
        • 11.2.1 North America G-CSF Biosimilars Production, Revenue Forecast (2019-2025)
        • 11.2.2 Europe G-CSF Biosimilars Production, Revenue Forecast (2019-2025)
        • 11.2.3 China G-CSF Biosimilars Production, Revenue Forecast (2019-2025)
        • 11.2.4 Japan G-CSF Biosimilars Production, Revenue Forecast (2019-2025)
      • 11.3 Global G-CSF Biosimilars Consumption Forecast by Regions (2019-2025)
        • 11.3.1 North America G-CSF Biosimilars Consumption Forecast (2019-2025)
        • 11.3.2 Europe G-CSF Biosimilars Consumption Forecast (2019-2025)
        • 11.3.3 China G-CSF Biosimilars Consumption Forecast (2019-2025)
        • 11.3.4 Japan G-CSF Biosimilars Consumption Forecast (2019-2025)
      • 11.4 Global G-CSF Biosimilars Production, Revenue and Price Forecast by Type (2019-2025)
      • 11.5 Global G-CSF Biosimilars Consumption Forecast by Application (2019-2025)

      12 Research Findings and Conclusion

        13 Methodology and Data Source

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        Granulocyte colony-stimulating factor (G-CSF) is a glycoprotein containing 174 amino acids with a molecular weight of about 20000.
        The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World. Annual estimates and forecasts are provided for the period 2018 through 2025. Also, a five-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research.
        This report analyzes the worldwide markets for G-CSF Biosimilars in US$ by the following Product Segments: Human growth hormone, Erythropoietin, Monoclonal antibodies, Insulin, Interferon, Granulocyte-Colony Stimulating Factor
        Company profiles are primarily based on public domain information including company
        Merck & Co.
        Sanofi
        Johnson & Johnson
        Gilead Science
        GlaxoSmithKline
        AbbVie
        Amgen
        AstraZeneca
        Bayer
        Pfizer
        Novartis
        Roche

        The global G-CSF Biosimilars market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
        This report focuses on G-CSF Biosimilars volume and value at global level, regional level and company level. From a global perspective, this report represents overall G-CSF Biosimilars market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
        At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

        The following manufacturers are covered:
        Pfizer
        Novartis
        Roche
        Merck & Co.
        Sanofi
        Johnson & Johnson
        Gilead Science
        GlaxoSmithKline
        AbbVie
        Amgen
        AstraZeneca
        Bayer

        Segment by Regions
        North America
        Europe
        China
        Japan

        Segment by Type
        Human Growth Hormone
        Erythropoietin
        Monoclonal Antibodies
        Insulin
        Interferon
        Granulocyte-Colony Stimulating Factor

        Segment by Application
        Blood Disorders
        Oncology Diseases
        Chronic And Autoimmune Diseases
        Growth Hormone Deficiencies

        Buy now